Linde plc (LIN)

Nasdaq Materials Industrial Gases S&P 500Nasdaq-100
$515.25
-5.98 (-1.15%)
Close of Nov 06, 2026 · end-of-day data

LIN 8-K filings, explained

Every material Form 8-K Linde has filed with the SEC since November 20, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs on record7since Nov 20, 2025
Latest filingOct 29, 2026earnings
High impact (4-5)0of 7 briefs
TonePositive2Mixed2Neutral3
earnings 4financing 3
Oct 29, 7:10 AM ET

Linde Reports Third-Quarter 2026 Sales of $9.4 Billion and Adjusted EPS of $4.59

Mixed earnings 2.02

Linde plc reported third-quarter 2026 sales of $9.4 billion, representing a 9% increase year-over-year, alongside net income of $1,692 million and diluted EPS of $3.66. On an adjusted basis, operating profit reached $2.8 billion and adjusted diluted EPS rose 9% to $4.59, while management updated full-year 2026 adjusted EPS guidance to a range of $17.82 to $17.92.

  • Third-quarter 2026 sales reached $9.4 billion, up 9% year-over-year, with underlying sales growing 5%.
  • Adjusted diluted earnings per share for the quarter were $4.59, up 9% compared to the prior-year period.
  • Operating cash flow for the quarter was $3.2 billion, an increase of 8% year-over-year.
  • Full-year 2026 adjusted diluted EPS guidance was set at $17.82 to $17.92.
Read the filing on SEC.gov ↗
Jul 31, 7:24 AM ET

Linde Q2 2026 sales rise 9% to $9.3 billion; adjusted EPS up 10% to $4.50

Positive earnings Written later 2.02

Linde plc reported second-quarter 2026 sales of $9.3 billion, up 9% from a year earlier, and GAAP diluted EPS of $4.15, up 11%. The company also guided to full-year 2026 adjusted EPS of $17.70 to $17.90, representing 8% to 9% growth, which signals continued earnings growth for shareholders although operating margin fell 60 basis points.

  • Q2 2026 sales were $9,289 million, up 9%, with underlying sales up 4% from 2% price and 2% volume
  • Adjusted EPS was $4.50, up 10%; GAAP diluted EPS was $4.15, up 11%
  • Full-year 2026 adjusted EPS guidance is $17.70 to $17.90; third-quarter guidance is $4.45 to $4.55
  • Operating margin was 27.5% and adjusted operating margin 29.5%, with operating margin 60 basis points lower than the prior year
Read the filing on SEC.gov ↗
May 13, 4:01 PM ET

Linde issues €1.6 billion in euro notes across 2028, 2030 and 2036 maturities

Neutral financing Written later 8.01

Linde plc issued three series of euro-denominated notes on May 13, 2026, totaling €1.6 billion in net proceeds after manager fees. The company said the proceeds will fund general corporate purposes, and the filing describes a new issuance under its €25 billion European debt program.

  • Issued €600 million Floating Rate Notes due 2028, €500 million 3.200% Notes due 2030 and €500 million 3.800% Notes due 2036
  • Net proceeds of approximately €1,595 million after fees to the managers, before other offering expenses
  • Notes were admitted to the Luxembourg Stock Exchange, and the program base prospectus is dated May 4, 2026
Read the filing on SEC.gov ↗
May 1, 6:47 AM ET

Linde Q1 adjusted EPS up 10% to $4.33; 2026 outlook $17.60-$17.90

Positive earnings Written later 2.02

Linde reported first-quarter 2026 sales of $8.8 billion, up 8% from a year earlier, and diluted EPS of $3.98, up 13%. The company also projected full-year 2026 adjusted EPS of $17.60 to $17.90, which it says is 7% to 9% growth, and second-quarter adjusted EPS of $4.40 to $4.50.

  • Q1 2026 sales $8.8 billion, up 8%; underlying sales up 3%
  • Reported diluted EPS $3.98, up 13%; adjusted EPS $4.33, up 10%
  • Adjusted operating margin 30.0%, down 10 basis points year over year
  • 2026 adjusted EPS guidance $17.60-$17.90; Q2 2026 guidance $4.40-$4.50
Read the filing on SEC.gov ↗
Feb 5, 7:47 AM ET

Linde Q4 2025 sales rise 6% to $8.8 billion; GAAP EPS falls 9% to $3.26

Mixed earnings Written later 2.02

Linde reported fourth-quarter 2025 sales of $8,764 million, up 6%, and adjusted EPS of $4.20, up 6%, while GAAP diluted EPS fell 9% to $3.26 and net income fell 11% to $1,530 million. The company guided 2026 adjusted diluted EPS to $17.40 to $17.90, up 6% to 9%, which gives shareholders a forward profit range but also highlights a gap between adjusted and GAAP results.

  • Q4 2025 sales $8,764 million, up 6%; underlying sales up 3%
  • Q4 2025 GAAP diluted EPS $3.26, down 9%; adjusted EPS $4.20, up 6%
  • 2026 full-year adjusted EPS guidance $17.40 to $17.90; Q1 2026 guidance $4.20 to $4.30
  • Full-year 2025 returned $7.4 billion to shareholders through dividends and share repurchases
Read the filing on SEC.gov ↗
Dec 3, 4:03 PM ET

Linde signs $1.5 billion unsecured 364-day revolving credit agreement with Bank of America

Neutral financing Written later 1.012.03

Linde plc and certain subsidiaries entered into an unsecured 364-day revolving credit agreement with total commitments of $1.5 billion, led by Bank of America, N.A. as administrative agent. The facility is for general corporate purposes and, as of the filing date, has no usage outstanding.

  • Total commitments under the credit agreement are $1,500,000,000, signed December 3, 2025
  • Commitments expire 364 days after the agreement date; borrowings can be converted into term loans due one year after expiry
  • Revolving loans bear interest based on SOFR, EURIBOR, SONIA or the base rate plus a ratings-based margin; no financial maintenance covenant
  • No amount was outstanding under the facility as of the filing date
Read the filing on SEC.gov ↗
Nov 20, 4:01 PM ET

Linde issues €1,750 million in euro notes due 2027, 2032 and 2038 to fund general purposes

Neutral financing Written later 8.01

Linde plc issued three series of euro-denominated notes on November 20, 2025, totaling €1,750 million in principal: €600 million of floating rate notes due 2027, €650 million of 3.125% notes due 2032, and €500 million of 3.750% notes due 2038. Net proceeds were approximately €1,737 million after fees to the managers, and will be used for general corporate purposes. For shareholders, this is a routine debt financing under an existing program rather than a change in operations or earnings.

  • Issued €600 million floating rate notes due 2027, €650 million 3.125% notes due 2032 and €500 million 3.750% notes due 2038 on November 20, 2025
  • Net proceeds of approximately €1,737 million, after fees to the managers but before other offering expenses
  • Proceeds will be used for general corporate purposes; notes were issued under a €20 billion European debt program
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Linde filing is on SEC EDGAR ↗. 8-K briefs of other companies →